Assault lawyers in Texas work hard for their clients charged with assault, aggravated assault, domestic assault or assault with a deadly weapon. The most common charge of assault is an intentional threat of violence combined with the actual infliction of violence upon a victim. Being charged with assault in the state of Texas is extremely serious—assault lawyers in Texas know the charges can range from a Class C misdemeanor to a first degree felony. The level of charges will hinge on whether actual physical harm was done to another person as opposed to mere threats or unwanted contact

 

Thousands of innocent patients have been forced to undergo hip replacement surgery after their metal-on-metal hip implant failed or caused symptoms of metal toxicity. The primary question on the minds of these victims may well be--How do I know if my Stryker hip was recalled? While many of those who received a Stryker ABGII or Rejuvenate received a letter from the manufacturer informing them of the recall in July, 2012, there are those who received no notification. Medical device manufacturers do not typically know exactly which patients have been implanted with their hip devices, they know only which hospitals and doctors order their implants.

Victoza, a drug approved for the treatment of Type 2 diabetes, gained FDA approval in 2010 and was touted as an amazing new injectable diabetic drug which only required once-daily injections and was not dependent upon the food eaten or the level of activity. Over 26 million people in the United States are affected by diabetes therefore the market for diabetic drugs has literally skyrocketed. At the time Victoza was submitted by its manufacturer, Novo Nordisk, for FDA approval, there were two FDA pharmacologists and one FDA clinical safety reviewer who did not believe the drug warranted approval until further safety studies were conducted. 

Januvia, a drug approved in 2006 by the FDA to be used in the treatment of Type 2 diabetes, has been found to bring a risk of pancreatitis, pancreatic cancer and thyroid cancer among users. Reports of 88 serious cases of pancreatitis were sent to the FDA between the time Januvia was approved and 2009. Of these 88 cases, over half resolved when Januvia was discontinued. At least one-fifth of the patients had only been taking Januvia for a month or less and 75% of the patients required hospitalization. 

Lawsuits Resulting from Stryker’s Rejuvenate and ABGII Hip Stem Recall to be Transferred to the District of Minnesota’s U.S. District Court...